Andrew Farquharson
CIK: 0001865699
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rani Therapeutics Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 28, 2025RANI
Rani Therapeutics Holdings, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
50K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
Disposition(D)DirectStock Option (Right to Buy)
101.3K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
Award(A)DirectStock Option (Right to Buy)
101.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 28, 2025 | RANI Rani Therapeutics Holdings, Inc. | Award(A) Director Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Disposition(D) Stock Option (Right to Buy) | 101,276 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Award(A) Stock Option (Right to Buy) | 101,276 | - | - | Direct |
1-3 of 3 transactions
About Farquharson Andrew
Farquharson Andrew (SEC CIK 0001865699) files insider reports with the SEC as Director of Rani Therapeutics Holdings, Inc. (RANI).
Signal8 holds 2 ownership filings by Farquharson Andrew, all Form 4s, filed between Dec 17, 2024 and May 30, 2025. Those filings report 3 transactions, from Dec 16, 2024 to May 28, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Farquharson Andrew's filings is in SAN JOSE, CA.
Recent filings by Farquharson Andrew
Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)
- Imran Talat, Chief Executive Officer
- Javadi Alireza, Chief Technical Officer
- Gilson Michelle, Director
- IMRAN MIR A, Director
- Maestas Nicholas, Chief Financial Officer
- McKinley Kate, Chief Business Officer